Apr 25, 2013 04:05PM Hyperion Therapeutics to Present at Needham's 12th Annual Healthcare Conference

Mar 8, 2013 09:16AM Hyperion (HPTX) Prices 2.88M Common Follow-On Offering

Feb 26, 2013 09:06AM Needham & Company Maintains Buy on Hyperion Therapeutics (HPTX) Post Q4

Feb 4, 2013 03:12PM Needham & Company Raises PT on Hyperion Therapeutics (HPTX) to $25 after FDA Approval for Ravicti

Aug 20, 2012 10:57AM Notable Analyst Rating Changes 08/20: (ROST) (PB) (STO) Upgraded; (STEM) (STX) (PCYC) Downgraded

Aug 20, 2012 07:36AM Needham & Company Starts Hyperion Therapeutics (HPTX) at Buy; Commercial Opportunity for Navicti

Jul 26, 2012 11:11AM Hyperion Therapeutics (HPTX) IPO Trades Slightly Higher

Apr 13, 2012 06:46AM Hyperion Therapeutics (HPTX) Files $57.5M IPO